AU Patent

AU2019246753B2 — Novel compounds and compositions for inhibition of FASN

Assigned to Forma Therapeutics Inc · Expires 2020-10-22 · 6y expired

What this patent protects

C:\Interwoen\NRPortbl\DCC\RBR\19392378_l.doex-7/l0/2019 ABSTRACT The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the 5 invention is shown below: 0 HO H N o N

USPTO Abstract

C:\Interwoen\NRPortbl\DCC\RBR\19392378_l.doex-7/l0/2019 ABSTRACT The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the 5 invention is shown below: 0 HO H N o N

Drugs covered by this patent

Patent Metadata

Patent number
AU2019246753B2
Jurisdiction
AU
Classification
—
Expires
2020-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Forma Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.